Vizgen Advances Spatial Genomics Research with New Program
Vizgen releases new dataset generated by Vizgen’s MERSCOPE™ which includes a high-resolution spatial map of GPCR and RTK expression within the mouse brain Vizgen, the life...
Tag : next generation sequencing
Deep Genomics to Participate in Citi PCA
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today that its Founder and Chief Executive Officer, Brendan Frey, Ph.D., F.R.S.C., will participate in...
Verge Genomics Names Robert Scannevin, Chief Scientific Officer
Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today that Robert...
Gene-editing Company Kiromic Announces 6 Posters Presented at AACR
Kiromic BioPharma, Inc. (Nasdaq: KRBP), an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform (Diamond AI) to develop novel...
Deep Genomics Appoints Jeffrey M. Brown, VP Preclinical Research
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the appointment of Jeffrey Brown, Ph.D., Vice President, Preclinical Research. Jeffrey will be responsible...
EchelonDx and Cradle Genomics Join Forces
Complementary technologies will transform data analysis and reporting capabilities for prenatal diagnostic testing Echelon Diagnostics, Inc., a leading provider of genomic healthcare AI imaging analysis...
Gene Therapy Developer Capsida Biotherapeutics Debuts with $140M
– Versant, Westlake Village BioPartners launch next-generation gene therapy company with $50 million Series A – – Collaboration with AbbVie provides $90 million in up...
Veracyte to Unveil Practice-Changing Genomic Diagnostics Data
– Pivotal clinical validation data for Percepta Nasal Swab test in early lung cancer detection – – New data demonstrating ability of Decipher Prostate test...
Illumina to Donate $60M for a Global Pathogen Genomics Initiative
Illumina, Inc. (NASDAQ: ILMN) has committed US $60 million in sequencing capabilities to a global pathogen genomics initiative, in partnership with the Bill & Melinda...
Twist Bioscience and Genomic Tool Provider, Vivlion Partner
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Vivlion GmbH,...